Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for Northwest Biotherapeutics (NWBO) over the last 15 years, with Q3 2025 value amounting to $475000.0.

  • Northwest Biotherapeutics' Long-Term Debt Repayments fell 1379.31% to $475000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 5820.36%. This contributed to the annual value of $1.1 million for FY2024, which is 18831.17% up from last year.
  • Northwest Biotherapeutics' Long-Term Debt Repayments amounted to $475000.0 in Q3 2025, which was down 1379.31% from $536000.0 recorded in Q1 2025.
  • Northwest Biotherapeutics' 5-year Long-Term Debt Repayments high stood at $4.0 million for Q1 2022, and its period low was $2000.0 during Q3 2023.
  • Its 5-year average for Long-Term Debt Repayments is $909928.6, with a median of $392500.0 in 2024.
  • Per our database at Business Quant, Northwest Biotherapeutics' Long-Term Debt Repayments plummeted by 9800.0% in 2023 and then soared by 2745000.0% in 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments (Quarter) stood at $3.8 million in 2021, then plummeted by 97.41% to $99000.0 in 2022, then soared by 76.77% to $175000.0 in 2023, then soared by 77.14% to $310000.0 in 2024, then skyrocketed by 53.23% to $475000.0 in 2025.
  • Its last three reported values are $475000.0 in Q3 2025, $536000.0 for Q1 2025, and $310000.0 during Q4 2024.